PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Clinical Research Development Center (CRDC), Sayad Shirazi Hospital, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran. s_besharat_gp@yahoo.com.\', \'Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. s_besharat_gp@yahoo.com.\', \'Cancer Research Center, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Clinical Research Development Unit (CRDU), 5th Azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran.\', \'Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran. shirzad.hessam1364@gmail.com.\', \'Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran. roshandel_md@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-04499-5
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 32560745
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all